Blog

Top 5 recommendations for successful interactive value messaging in life sciences

Explore 5 proven tips for effective interactive value messaging in market access & life sciences…

CertaraAugust 22, 2025

On-Demand Webinar

Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value

Discover strategies to cut risk, speed timelines, and boost investor confidence in early biotech development.

CertaraAugust 21, 2025

On-Demand Webinar

ToxStudio®: In silico tools to accelerate toxicology assessments

Watch to explore ToxStudio—in silico toxicology platform designed to address key preclinical safety challenges.

CertaraAugust 19, 2025

On-Demand Webinar

The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar

Watch Certara’s RAPS-sponsored on-demand webinar to learn how automation and expert strategies simplify patient narrative…

CertaraAugust 18, 2025

Case Study

Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management

Find out how Certara helped a small biotech achieve on-time IND and CTA submissions with…

CertaraAugust 18, 2025

Publication

Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers

Find out how palbociclib formulations are bioequivalent under fasting and fed conditions using Phoenix WinNonlin

CertaraAugust 18, 2025

Conference

BioTechX US 2025

– – Booth

Simona ColucciAugust 15, 2025

Blog

Accelerate your SDTM mapping with Pinnacle 21 Enterprise plus

Streamline your SDTM mapping with Pinnacle 21 Enterprise. Discover how innovation and efficiency enhance data…

Gilbert HunterAugust 13, 2025

Publication

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

CertaraAugust 13, 2025

Publication

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…

CertaraAugust 13, 2025

Top 5 recommendations for successful interactive value messaging in life sciences

Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value

ToxStudio®: In silico tools to accelerate toxicology assessments

The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar

Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management

Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers

BioTechX US 2025

Accelerate your SDTM mapping with Pinnacle 21 Enterprise plus

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Newsletter sign up

Quick links

Solutions

Contact